⌘K
Loading ticker…
MacroGenics, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, MacroGenics, Inc. (MGNX) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 89. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.3%, relative volume 10.58×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 90, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
MGNX is in a stage 2 uptrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 25.5% / 100.2%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
MGNX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $6M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $6M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MGNX Jan avg: 10.15% median: 2.99% win: 50% σ: 28.26% n: 4 2022-04-12 → 2026-05-29 | MGNX Feb avg: 5.44% median: 7.14% win: 75% σ: 17.90% n: 4 2022-04-12 → 2026-05-29 | MGNX Mar avg: -0.84% median: -0.11% win: 50% σ: 40.90% n: 4 2022-04-12 → 2026-05-29 | MGNX Apr avg: 5.23% median: 0.41% win: 60% σ: 19.01% n: 5 2022-04-12 → 2026-05-29 | MGNX May avg: -28.51% median: -32.22% win: 20% σ: 40.47% n: 5 2022-04-12 → 2026-05-29 | MGNX Jun avg: -1.88% median: -3.56% win: 50% σ: 13.65% n: 4 2022-04-12 → 2026-05-29 (current) | MGNX Jul avg: 3.16% median: -2.37% win: 50% σ: 19.01% n: 4 2022-04-12 → 2026-05-29 | MGNX Aug avg: 7.84% median: 5.58% win: 50% σ: 15.33% n: 4 2022-04-12 → 2026-05-29 | MGNX Sep avg: -6.05% median: -5.68% win: 0% σ: 5.28% n: 4 2022-04-12 → 2026-05-29 | MGNX Oct avg: 17.51% median: 11.63% win: 75% σ: 21.19% n: 4 2022-04-12 → 2026-05-29 | MGNX Nov avg: 18.28% median: 11.84% win: 50% σ: 29.80% n: 4 2022-04-12 → 2026-05-29 | MGNX Dec avg: 4.32% median: 4.79% win: 75% σ: 10.90% n: 4 2022-04-12 → 2026-05-29 |